Functional genomics complements quantitative genetics in identifying disease-gene associations
Yuanfang Guan1, Cheryl L Ackert-Bicknell, Braden Kell
1Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
Plos Computational Biology
|November 19, 2010
Summary
This study introduces a new computational method to link genes with traits by analyzing functional genomics data. This approach improves the prediction of disease-associated genes, offering new insights beyond traditional genetic studies.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Understanding genotype-phenotype connections is crucial for disease diagnosis and treatment.
- Traditional methods like quantitative trait loci (QTL) and genome-wide association studies (GWAS) have limitations in resolution and explained heritable variation.
- Predictive power and interpretation of existing genetic studies are often constrained.
Purpose of the Study:
- To develop a complementary approach to quantitative genetics for associating genes with phenotypes and diseases.
- To leverage high-throughput genomic data in model organisms for functional gene-phenotype associations.
- To improve the accuracy and interpretability of genetic predictions for disease risk.
Main Methods:
- Developed an algorithm combining a mouse genome-wide functional relationship network with machine learning.
- Applied the algorithm to predict genes associated with 1157 diverse phenotype ontology terms.
- Validated novel predictions experimentally, focusing on bone mineral density (BMD).
Main Results:
- The algorithm demonstrated superior accuracy in predicting gene-phenotype associations.
- Comparison with quantitative genetics meta-analyses revealed overlapping and novel predictions.
- Experimental validation confirmed two novel gene predictions (Timp2 and Abcg8) associated with significant bone density defects.
Conclusions:
- Integrating functional genomics data into networks provides a powerful complementary approach to quantitative genetics.
- This method enhances the prediction of disease risks and identifies novel gene-phenotype relationships.
- The findings support the use of network-based functional genomics for advancing genetic research and disease understanding.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Complementation Tests
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...


